MAP2K1 and diffuse large B-cell lymphoma: It is known that the oncogenic mutation in growth factor receptor-bound protein 2 (GRB2), which mediates growth factors and RAS-MAPK signaling, governs MEK1/2 activities downstream at MAP-kinase in DLBCL-type PCNSL [36].